Abstract:Background Lung cancer is the most prevalent and lethal cancer globally, necessitating accurate differentiation between benign and malignant pulmonary nodules to guide treatment decisions. This study aims to develop a predictive model that integrates artificial intelligence (AI) analysis with biomarkers to enhance early detection and stratification of lung nodule malignancy. Methods The study retrospectively analyzed the patients with pathologically confirmed pulmonary nodules. AI technology was employed to assess CT features, such as nodule size, solidity, and malignancy probability. Additionally, lung cancer blood biomarkers were measured. Statistical analysis involved univariate analysis to identify significant differences among factors, followed by multivariate logistic regression to establish independent risk factors. The model performance was validated using receiver operating characteristic curves and decision curve analysis (DCA) for internal validation. Furthermore, an external dataset comprising 51 cases of lung nodules was utilized for independent validation to assess robustness and generalizability. Results A total of 176 patients were included, divided into benign/preinvasive ( n = 76) and invasive cancer groups ( n = 100). Multivariate analysis identified eight independent predictors of malignancy: lobulation sign, bronchial inflation sign, AI-predicted malignancy probability, nodule nature, diameter, solidity proportion, vascular endothelial growth factor, and lung cancer autoantibodies. The combined predictive model demonstrated high accuracy (area under the curve [AUC] = 0.946). DCA showed that the combined model significantly outperformed the traditional model, and also proved superior to models using AI-predicted malignancy probability or the seven lung cancer autoantibodies plus traditional model. External validation confirmed its robustness (AUC = 0.856), achieving a sensitivity of 0.80 and specificity of 0.86, effectively distinguishing between invasive and noninvasive nodules. Conclusion This combined approach of AI-based CT features analysis with lung cancer biomarkers provides a more accurate and clinically useful tool for guiding treatment decisions in pulmonary nodule patients. Further studies with larger cohorts are warranted to validate these findings across diverse patient populations. Received: 07 May 2024 Accepted: 01 October 2024 Article published online: 26 November 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

CT and CEA‐based Machine Learning Model for Predicting Malignant Pulmonary Nodules

Development and Validation of Machine Learning–based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts

AI-enhanced diagnostic model for pulmonary nodule classification

A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules

A prediction model based on computed tomography characteristics for identifying malignant from benign sub-centimeter solid pulmonary nodules

Predicting the Malignancy of Pulmonary Nodules Using Baseline Chest CT: an Application Study of Deep Learning Model

[Establishment and Verification of A Novel Predictive Model of Malignancy for Non-solid Pulmonary Nodules]

A combinatorial model of plasma proteins and LDCT imaging and the diagnosis of pulmonary nodules.

Application value of the automated machine learning model based on modified CT index combined with serological indices in the early prediction of lung cancer

Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models

Establishment and verification of a prediction model based on clinical characteristics and computed tomography radiomics parameters for distinguishing benign and malignant pulmonary nodules

A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules

Establishment and validation of multiclassification prediction models for pulmonary nodules based on machine learning

A Predictive Model Integrating AI Recognition Technology and Biomarkers for Lung Nodule Assessment

Comprehensive Analysis of Clinical Logistic and Machine Learning-Based Models for the Evaluation of Pulmonary Nodules

Quantitative Analysis of Chest MRI Images for Benign Malignant Diagnosis of Pulmonary Solid Nodules

Risk assessment of malignancy in solitary pulmonary nodules in lung computed tomography: a multivariable predictive model study

Using a risk model for probability of cancer in pulmonary nodules

An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary Subsolid Nodules Based on Current and Prior CT Scans.

Classification of Solid Pulmonary Nodules Using a Machine-Learning Nomogram Based on 18F-FDG PET/CT Radiomics Integrated Clinicobiological Features.

Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches